MétaCan
Menu
Retour à la cohorte
Enregistrement W4405046734 · doi:10.1182/blood-2024-211092

Routine Prophylactic Granulocyte Colony-Stimulating Factor Use Post Autologous Peripheral Blood Stem Cell Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Germ Cell Tumors Shortens Duration of Hospital Stay and Reduces Mortality: A Retrospective Single Center Experience

2024· article· en· W4405046734 sur OpenAlexaffabout
Neelan Sriranjan, Shanee Chung, Hannah Cherniawsky, Donna L. Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J. Stubbins, Cynthia L. Toze, Jennifer White, Yasser Abou Mourad

Notice bibliographique

RevueBlood · 2024
Typearticle
Langueen
DomaineMedicine
ThématiqueNeutropenia and Cancer Infections
Établissements canadiensBC Cancer AgencyUniversity of British ColumbiaVancouver General Hospital
Organismes subventionnairesnon disponible
Mots-clésMedicineGranulocyte colony-stimulating factorLymphomaTransplantationStem cellPeripheral Blood Stem CellsAutologous stem-cell transplantationNon-Hodgkin's lymphomaOncologyInternal medicineHematopoietic stem cell transplantationImmunologyChemotherapyBiology

Résumé

récupéré en direct d'OpenAlex

Background: High-dose chemotherapy followed by autologous stem cell transplant (HDC/AutoSCT) is an effective therapy for various chemo-sensitive malignancies. Post-transplant complications often occur during the cytopenic period, which synthetic Granulocyte Colony Stimulating Factor (G-CSF) can shorten. G-CSF use is linked to faster engraftment and shorter hospital stays, though it hasn't shown benefits for overall survival (OS). At Vancouver General Hospital, we shifted from therapeutic G-CSF (TGCSF) to prophylactic G-CSF (PGCSF) for HDC/AutoSCT in 2019. This single-centre experience compares patient outcomes between routine PGCSF use and a historical group with TGCSF. Methods: This single-centre experience includes 581 patients who received HDC/AutoSCT from June 2015 to June 2023. Patients from June 2015 to May 2019 (285) received TGCSF, which meant patients only received G-CSF when there were concerns of delayed engraftment, febrile neutropenia, or infections. Patients from June 2019 to June 2023 (296) received PGCSF starting on day +7 post stem cell re-infusion. Data was collected by reviewing electronic charts and our BMT electronic database for 581 transplants performed at the L/BMT program of British Columbia, Canada during this specified period. Baseline demographics, patients' characteristics, primary disease, disease status prior to HDC/AutoSCT, conditioning HDC, stem cell dose, complications, length of stay (LOS) in hospital, number of infections, presence of mucositis, mucositis severity, days to engraftment, transfusions required, cell dose, presence of engraftment syndrome, number of re-admissions, mortality at three months and at six months were all collected. Comparison of continuous variables between the groups were performed using two-sample t-test with unequal variance and that of dichotomous variables using Chi-square test. The statistical program used was STATA version 18.0 (Texas, 2023). Results: Baseline characteristics included median ages of 54 years (18-72) in the TGCSF group and 57.5 years (18-72) in the PGCSF group (p=0.06). The TGCSF group had higher proportions of males (70.6% vs. 63.9% (p=0.083)). The primary diseases treated were non-Hodgkin's lymphoma, Hodgkin's lymphoma, and germ cell tumors representing 74%, 21%, and 2% in the TGCSF group respectively compared to 69%, 17%, and 11% in the PGCSF group. Other disease indications encompassed 3% in both groups. The most common conditioning regimen was BEAM, used in 74% of TGCSF and 68% of PGCSF transplants. The TGCSF group had a higher median cell dose (9.66 x 10^8 cells/Kg vs. 7.96 x 10^8 cells/Kg) and a greater proportion of patients in a partial or complete response prior to HDC/AutoSCT (52% vs. 44%). Despite higher cell doses and better disease control in the TGCSF group, the PGCSF group showed faster neutrophil engraftment (11.4 vs. 10.4 days (p<0.001)) but no difference in platelet engraftment (10.1 vs 9.5 days (p=0.2679)). The PGCSF group also utilized less red cell units (1.78 vs. 1.28 (p< 0.001)) but equivalent adult platelet doses (3.6 vs. 3.1 (p=0.1223)). There was a three-day shorter hospital stay for the PGCSF group (23.3 vs 20.4 days (p<0.001)). Both groups had similar mucositis rates, but higher-grade mucositis was more common in the TGCSF group (33% vs. 23%). Mortality at 6 months and incidence of engraftment syndrome favored the PGCSF group (11% vs. 6% (p=0.055) and 4% vs. 5%). Mortality at 3 months was equivalent between the two groups. There were similarities between the two groups in number of infections, engraftment syndrome and number of readmissions. Discussion: In this large retrospective single-centre study, routine G-CSF (PGCSF) use in HDC/AutoSCT showed better outcomes with faster engraftment, less red cell transfusions, less severe mucositis and shorter hospital stay. Mortality at 6 months favored the routine use of G-CSF. Our retrospective review supports routine G-CSF use and shows an association with reduction in mortality with this strategy.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,001
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,003
Score d'incertitude au seuil0,006

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0000,001
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,001
Études des sciences et des technologies0,0000,000
Communication savante0,0010,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,015
Tête enseignante GPT0,259
Écart entre enseignants0,244 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2024
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueBloodMême sujetNeutropenia and Cancer InfectionsTravaux en français237 207